Melanoma Posts - Page 21 of 45 on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

How to Smoothie!

How to Smoothie!

Posted by on Jul 25, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

This summer has been a challenge after a family member with celiac disease had a gluten exposure (Click here to read more about celiac disease). Gluten damages the small intestine villi (see 5 Facts You Probably Didn’t Know About Your Small Intestines), which are essential for nutrition absorption.  For over a month, gastrointestinal pain, vomiting...

Read More

Infographic on Cancer Immunotherapy

Infographic on Cancer Immunotherapy

Posted by on Jul 12, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 5 comments

Last summer we provided a series of posts on oncology basics.  Oncology Basics: Preparing for ASCO covered some of the history of oncology.  In Understanding Cells, we reviewed what is newly understood about cells–it’s way beyond what you learned in high school biology.  DNA with lots of animated videos also explained some of the basics...

Read More

Dabrafenib combined with trametinib is associated with durable responses in metastatic melanoma

Dabrafenib combined with trametinib is associated with durable responses in metastatic melanoma

Posted by on Jun 28, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the effectiveness and safety of combined treatment with dabrafenib (Tafinlar) and trametinib (Mekinist) in patients with BRAF mutated stage 3 or 4 melanoma. Researchers suggested that the combination treatment has durable (3 years or more) results.   Some background Patients with metastatic (spread to...

Read More

Colon Cancer Patient Advocate Shares Her Story

Colon Cancer Patient Advocate Shares Her Story

Posted by on Jun 26, 2017 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 3 comments

In April, the American Association for Cancer Research (AACR) held a free education event on cancer called​ Progress and Promise Against Cancer in Washington, D.C.  Surrounded by experts in cancer research, Kim Hall Jackson shared her patient story. One evening in 2008, Jackson, an event planner, was running the mayor’s inaugural event in...

Read More

Can sentinel lymph node biopsy predict outcome in locally recurrent or in-transit melanomas?

Can sentinel lymph node biopsy predict outcome in locally recurrent or in-transit melanomas?

Posted by on Jun 5, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the role of sentinel node biopsy (SLNB) in locally recurrent (LR; when the cancer comes back) melanoma or in-transit (IT; spreads to a lymph vessel before it reaches the nearest lymph node) melanoma. Researchers suggested that SLNB should be performed in these patients. Some background The sentinel lymph node...

Read More

Quick Guide: Understanding the Importance of the FDA’s Keytruda Approval

Quick Guide:  Understanding the Importance of the FDA’s Keytruda Approval

Posted by on May 26, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Lung cancer, Melanoma, Prostate cancer | 2 comments

In July 2015, we published a post called Patients Included In Research: Studying Cancer by Mutation Not Organ.  In that post, we shared the goal that cancers would be treated not by the site of origin, but rather by their genetic features.  Achieving this goal is closer than you think! This week the FDA announced accelerated approval** of a...

Read More

Lactate dehydrogenase is an effective outcome predictive factor for melanoma treatment with PD-1 agents

Lactate dehydrogenase is an effective outcome predictive factor for melanoma treatment with PD-1 agents

Posted by on May 16, 2017 in Melanoma | 0 comments

In a nutshell This study investigated whether changes in lactate dehydrogenase (LDH) levels in the blood could predict treatment response to PD-1 agents. Researchers suggested that LDH could be a useful factor to predict treatment outcomes in patients with advanced melanoma.   Some background The use of PD-1 agents to treat melanoma is...

Read More

Carbon-ion radiation therapy is a safe treatment option for head and neck melanomas

Carbon-ion radiation therapy is a safe treatment option for head and neck melanomas

Posted by on May 8, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the effectiveness and safety of carbon-ion radiation therapy (CRT) for mucosal melanoma of the head and neck. Researchers suggested that CRT is an important treatment option for these patients. Some background Mucosal head and neck melanomas account for roughly 1% of all melanomas. However, is typically...

Read More